Mark Lifson

Dr. Mark Lifson

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2016 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
HIHakan Inan
Hakan Inan
MPMuhammet Poyraz
Muhammet Poyraz
Fatih InciFatih Inci
Fatih Inci
MLMark Lifson
Mark Lifson
MBMurat Baday
Murat Baday
UDUtkan Demirci
Utkan Demirci
This review describes photonic crystal-based biosensors and discusses their potential applications and promise at the point-of-care settings.

1 November 2016 in Trends in Biotechnology
Verified
Journal Article
Closed access
SWShuQi Wang
ShuQi Wang
TCThiruppathiraja Chinnasamy
Thiruppathiraja Chinnasamy
MLMark Lifson
Mark Lifson
Fatih InciFatih Inci
Fatih Inci
UDUtkan Demirci
Utkan Demirci

17 February 2016 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
SWShuQi Wang
ShuQi Wang
MLMark Lifson
Mark Lifson
Fatih InciFatih Inci
Fatih Inci
LLLi-Guo Liang
Li-Guo Liang
YSYe-Feng Sheng
Ye-Feng Sheng
UDUtkan Demirci
Utkan Demirci
The striking prevalence of HIV, TB and malaria, as well as outbreaks of emerging infectious diseases, such as influenza A (H7N9), Ebola and MERS, poses great challenges for patient care in resource...

1 August 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MLMark Lifson
Mark Lifson
MOMehmet O Ozen
Mehmet O Ozen
Fatih InciFatih Inci
Fatih Inci
SWShuQi Wang
ShuQi Wang
HIHakan Inan
Hakan Inan
UDUtkan Demirci
Utkan Demirci

12 June 2023
Verified
Conference Paper
Open access
JKJee Young Kim
Jee Young Kim
WBWilliam Boag
William Boag
FGFreya Gulamali
Freya Gulamali
AHAlifia Hasan
Alifia Hasan
HHHenry David Jeffry Hogg
Henry David Jeffry Hogg
MSMark Sendak
Mark Sendak
Private and public sector structures and norms refine how emerging technology is used in practice. In healthcare, despite a proliferation of AI adoption, the organizational governance (i.e. institutional governance) surrounding its use and integration is often poorly understood. What the Health AI Partnership (HAIP) aims to do in this research is to better define the requirements for adequate organizational governance of AI systems in healthcare settings and support health system leaders to make more informed decisions around AI adoption. To work towards this understanding, we first identify how the standards for the AI adoption in healthcare may be designed to be used easily and efficiently. Then, we map out the precise decision points involved in the practical institutional adoption of AI technology within specific health systems. Practically, we achieve this through a multi-organizational collaboration with leaders from major health systems across the United States and key informants from related fields. Working with the consultancy IDEO.org, we were able to conduct usability-testing sessions with healthcare and AI ethics professionals. Usability analysis revealed a prototype structured around mock key decision points that align with how organizational leaders approach technology adoption. Concurrently, we conducted semi-structured interviews with 89 professionals in healthcare and other relevant fields. Using a modified grounded theory approach, we were able to identify 8 key decision points and comprehensive procedures throughout the AI adoption lifecycle. This is one of the most detailed qualitative analyses to date of the current governance structures and processes involved in AI adoption by health systems in the United States. We hope these findings can inform future efforts to build capabilities to promote the safe, effective, and responsible adoption of emerging technologies in healthcare.

1 January 2008 in International Journal of Telemedicine and Applications
Verified
Journal Article
Open access
PDF file
SKSunil Kumar
Sunil Kumar
KKKashyap Kambhatla
Kashyap Kambhatla
FHFei Hu
Fei Hu
MLMark Lifson
Mark Lifson
Yang XiaoYang Xiao
Yang Xiao
New wireless technologies, such as wireless LAN and sensor networks, for telecardiology purposes give new possibilities for monitoring vital parameters with wearable biomedical sensors, and give patients the freedom to be mobile and still be under continuous monitoring and thereby better quality of patient care. This paper will detail the architecture and quality-of-service (QoS) characteristics in integrated wireless telecardiology platforms. It will also discuss the current promising hardware/software platforms for wireless cardiac monitoring. The design methodology and challenges are provided for realistic implementation.